A survey of antibiotic administration practices involving patients with sepsis in UK critical care units

Abstract

Background Alternative administration methods are emerging as a key area of research to improve clinical efficacy of antibiotics and address concerns regarding multi-drug resistance. Extended intermittent infusions or continuous infusions of antibiotics exhibiting time-dependent kill characteristics may be favourable in critically ill septic patients, but more evidence is needed to determine best practice. Objective To find out whether any common practice exists for intravenous antibiotic administration in critical care units across UK NHS Trusts, and identify factors influencing the adoption of extended or continuous infusions. Setting UK hospitals. Method UK critical care pharmacists were invited to participate in a survey on behalf of all 240 critical care units via a UK Clinical Pharmacy Association message board. The survey focused on administration practices for 22 antibacterial agents. Main outcome measure Antibiotic administration method. Results Responses were received covering 64 units, a response rate of 26.2%. Common, but not uniform administration methods were apparent for 17/22 antibiotics. Four antibiotics (piperacillin/tazobactam, doripenem, meropenem and vancomycin) were more likely to be administered as continuous or extended-intermittent infusions. Choice of administration method was especially influenced by altered pk/pd properties in sepsis or severe burns patients, or by the presence of organisms requiring high minimal inhibitory concentrations. Conclusion Unlicensed alternative practices of antibiotic administration are widespread but only weak evidence exists of any patient benefit, such as reduced length of stay in critical care, and none showing improvement in mortality. Further research is needed to determine whether extended infusion methods offer clinically meaningful advantages over shorter licenced administration methods in patients in critical care units.

Administration and Therapeutic Drug Monitoring of β-lactams and Vancomycin in Critical Care Units in Colombia: The ANTIBIOCOL Study

“…We can find similar results in France, where 77% of the participants were convinced of the value of using continuous infusion for β-lactams and vancomycin above other administration methods [29]. Nonetheless, several studies in the United Kingdom evidenced a lower preference for this type of infusion (as low as 20%), although the evidence was in favor of its use, which places Colombia in an encouraging prospect [17,36,37].…”

Prevalence and molecular characterization of foodborne and human‐derived Salmonella strains for resistance to critically important antibiotics

“…Four isolates also showed phenotypic resistance to piperacillin/tazobactam (TZP) and ticarcillin/clavulanic Acid. TZP is a critically important antimicrobial with a high priority that was approved to treat serious infections including pneumonia, intra‐abdominal infection, sepsis and febrile neutropenia (Barton et al., 2019). The current study looked at only three of the more than 340 β‐lactamase genes that have been described as having the ability to mediate resistance in Salmonella to β‐lactam antibiotics.…”

Salmonella enterica Infections Are Disrupted by Two Small Molecules That Accumulate within Phagosomes and Differentially Damage Bacterial Inner Membranes

“…Critically ill septic patients often have damage to endothelia and increased capillary leakage, which shifts fluid from body tissue to the interstitial space, diluting the plasma concentration of hydrophilic antibiotics and requiring higher and potentially toxic doses of hydrophilic antimicrobials for treatment ( 91 , 92 ). In contrast, lipophilic antimicrobials tend to diffuse more slowly from tissues upon capillary leakage and maintain their efficacy without the need for toxic doses ( 90 , 93 ). Despite these advantages, current lipophilic antibiotic therapies are imperfect at treating intracellular infections.…”